Literature DB >> 18157522

Anticonvulsant and anxiolytic-like effects of compounds isolated from Polygala sabulosa (Polygalaceae) in rodents: in vitro and in vivo interactions with benzodiazepine binding sites.

Filipe Silveira Duarte1, Mariel Marder, Alexandre Ademar Hoeller, Marcelo Duzzioni, Beatriz Garcia Mendes, Moacir Geraldo Pizzolatti, Thereza Christina Monteiro De Lima.   

Abstract

RATIONALE: Polygala sabulosa, a folk medicine, presents dihydrostyryl-2-pyrones (DST) and styryl-2-pyrones (STY), compounds structurally similar to kavalactones. Our previous study showed that the ethyl acetate fraction (EA) and these constituents present anxiolytic-like, hypno-sedative, and anticonvulsant effects in mice.
OBJECTIVES: This study investigated the role of benzodiazepine binding site (BDZ-bs) in the central effects of either EA or three DST (1, 2, and 3) and three STY (4, 5, and 7), using in vivo and in vitro assays. METHODS AND
RESULTS: In the elevated plus-maze (EPM), flumazenil (FMZ), a BDZ antagonist, partially blocked the anxiolytic-like effect of DST-3 or STY-4 and STY-7, but not DST-1. Using electroencephalogram (EEG), EA protected against pentylenetetrazole (PTZ)-induced convulsion in rats, an effect partially blocked by FMZ, suggesting the participation of the BDZ-bs in this action. EA also protected against the maximal electroshock (MES)-induced convulsions in mice, a profile distinct from diazepam (DZP). DST and STY compounds inhibited the [(3)H]-flunitrazepam ([(3)H]-FNZ) binding to BDZ-bs in rat cortical synaptosomes with K (i) higher than 100 microM (DST-1), 41.7 microM (DST-2), 35.8 microM (DST-3), 90.3 microM (STY-4), 31.0 microM (STY-5) and 70.0 microM (STY-7). In the saturation assay, DST-3 and STY-7 competitively inhibited the binding of [(3)H]-FNZ to BDZ-bs with a significant decrease in apparent affinity (K (d)) and no change in maximal binding (B (max)).
CONCLUSIONS: The present data support a partial BDZ-bs mediation of the anxiolytic-like and anticonvulsant effects of EA of P. sabulosa and its main isolated constituents, DST and STY.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18157522     DOI: 10.1007/s00213-007-1037-z

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  33 in total

1.  Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse.

Authors:  T J HALEY; W G MCCORMICK
Journal:  Br J Pharmacol Chemother       Date:  1957-03

Review 2.  New insights into the role of the GABA(A)-benzodiazepine receptor in psychiatric disorder.

Authors:  D J Nutt; A L Malizia
Journal:  Br J Psychiatry       Date:  2001-11       Impact factor: 9.319

Review 3.  GABAA/benzodiazepine receptor heterogeneity: neurophysiological implications.

Authors:  H Lüddens; E R Korpi; P H Seeburg
Journal:  Neuropharmacology       Date:  1995-03       Impact factor: 5.250

4.  Anti-anxiety studies on extracts of Passiflora incarnata Linneaus.

Authors:  K Dhawan; S Kumar; A Sharma
Journal:  J Ethnopharmacol       Date:  2001-12       Impact factor: 4.360

Review 5.  Antiepileptic drug mechanisms of action.

Authors:  R L Macdonald; K M Kelly
Journal:  Epilepsia       Date:  1995       Impact factor: 5.864

6.  SB-649915-B, a novel 5-HT1A/B autoreceptor antagonist and serotonin reuptake inhibitor, is anxiolytic and displays fast onset activity in the rat high light social interaction test.

Authors:  Kathryn R Starr; Gary W Price; Jeannette M Watson; Peter J Atkinson; Roberto Arban; Sergio Melotto; Lee A Dawson; Jim J Hagan; Neil Upton; Mark S Duxon
Journal:  Neuropsychopharmacology       Date:  2007-03-14       Impact factor: 7.853

7.  Non-GABAergic effects of midazolam, diazepam and flumazenil on voltage-dependent ion currents in NG108-15 cells.

Authors:  Y Ishizawa; K Furuya; S Yamagishi; S Dohi
Journal:  Neuroreport       Date:  1997-07-28       Impact factor: 1.837

8.  Timed pentylenetetrazol infusion test: a comparative analysis with s.c.PTZ and MES models of anticonvulsant screening in mice.

Authors:  Sanjay N Mandhane; Keerthikumar Aavula; T Rajamannar
Journal:  Seizure       Date:  2007-06-13       Impact factor: 3.184

Review 9.  Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy.

Authors:  Wolfgang Löscher
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

10.  Ethological comparison of the effects of diazepam and acute/chronic imipramine on the behaviour of mice in the elevated plus-maze.

Authors:  J C Cole; R J Rodgers
Journal:  Pharmacol Biochem Behav       Date:  1995-11       Impact factor: 3.533

View more
  10 in total

1.  Anxiogenic-like profile of Wistar adult rats based on the pilocarpine model: an animal model for trait anxiety?

Authors:  Filipe S Duarte; Marcelo Duzzioni; Alexandre A Hoeller; Nayana M Silva; Andy L Ern; Tetsade C Piermartiri; Carla I Tasca; Elaine C Gavioli; Tadeu Lemos; Antonio P Carobrez; Thereza C M De Lima
Journal:  Psychopharmacology (Berl)       Date:  2012-12-29       Impact factor: 4.530

2.  Polygala sabulosa A.W. Bennett extract mitigates motor and cognitive deficits in a mouse model of acute ischemia.

Authors:  Cristina Martins-Silva; Natalie de Souza Pinho; Glenda G Ferreira; Rafael Moraes Aguiar; Tamara Alarcon Ferreira; Rita G W Pires; Tiago Tizziani; Moacir G Pizzolatti; Adair R S Santos
Journal:  Metab Brain Dis       Date:  2021-01-04       Impact factor: 3.584

3.  Short- and long-term anxiogenic effects induced by a single injection of subconvulsant doses of pilocarpine in rats: investigation of the putative role of hippocampal pathways.

Authors:  Filipe Silveira Duarte; Elaine Cristina Gavioli; Marcelo Duzzioni; Alexandre Ademar Hoeller; Newton Sabino Canteras; Thereza Christina Monteiro De Lima
Journal:  Psychopharmacology (Berl)       Date:  2010-08-28       Impact factor: 4.530

4.  Effects of environmental enrichment on sensitivity to cocaine in female rats: importance of control rates of behavior.

Authors:  Mark A Smith; Jordan C Iordanou; Marika B Cohen; Kathryn T Cole; Samantha R Gergans; Megan A Lyle; Karl T Schmidt
Journal:  Behav Pharmacol       Date:  2009-07       Impact factor: 2.293

5.  Anxiolytic-like effects of compound zhi zhu xiang in rats.

Authors:  Yan-Li Wang; Jin-Li Shi; Liu Yong; Zhao Ren; Yu-Jing Zhai; Jian-You Guo
Journal:  Evid Based Complement Alternat Med       Date:  2012-05-29       Impact factor: 2.629

6.  Anticonvulsant potential of ethanol extracts and their solvent partitioned fractions from Flemingia strobilifera root.

Authors:  Kavita Gahlot; Vijay Kumar Lal; Shivesh Jha
Journal:  Pharmacognosy Res       Date:  2013-10

7.  Psychopharmacological effects and safety of styryl-2-pyrones and dihydrostyryl-2-pyrones-rich fraction from Polygala sabulosa: absence of withdrawal syndrome and tolerance to anxiolytic-like and anticonvulsant effects.

Authors:  Filipe Silveira Duarte; Marcelo Duzzioni; Rafael Luiz Prim; Alcíbia Maia Cardozo; Claudia Regina Dos Santos; Maria Goretti da Silva; Maria Beatriz Cacese Shiozawa; Beatriz Garcia Mendes; Tiago Tizziani; Inês Maria Costa Brighente; Moacir Geraldo Pizzolatti; Thereza Christina Monteiro de Lima
Journal:  J Pharm Pharmacol       Date:  2018-06-28       Impact factor: 3.765

Review 8.  Research progress in the biological activities of 3,4,5-trimethoxycinnamic acid (TMCA) derivatives.

Authors:  Zefeng Zhao; Huanhuan Song; Jing Xie; Tian Liu; Xue Zhao; Xufei Chen; Xirui He; Shaoping Wu; Yongmin Zhang; Xiaohui Zheng
Journal:  Eur J Med Chem       Date:  2019-04-06       Impact factor: 6.514

9.  Antifungal activity of five species of Polygala.

Authors:  Susana Johann; Beatriz G Mendes; Fabiana C Missau; Maria A de Resende; Moacir G Pizzolatti
Journal:  Braz J Microbiol       Date:  2011-09-01       Impact factor: 2.476

10.  Potential mechanisms involved in the anticonvulsant effect of walnut extract on pentylenetetrazole-induced seizure.

Authors:  Majid Asadi-Shekaari; Azam Eslami; Tajpari Kalantaripour; Siyavash Joukar
Journal:  Med Princ Pract       Date:  2014-09-04       Impact factor: 1.927

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.